Welcome to Nature’s Bioceuticals Online Store


Due To High Demand Nature’s Bioceuticals Shortens Timeline For Rollout Of Formulas

Cape Coral, FL- December 14, 2011   
 
Nature’s Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk - News) announced that it has received an unexpected volume of calls from people desirous of trying their products. As a result, Nature’s Bioceuticals has expedited the manufacturing and rollout of a number of their products.
 
As a result of the high demand, senior management of Nature’s met with their manufacturer yesterday to discuss shortening the timeline for the rollout of a number of products. It was decided that they intend to have the quality control measures in place, approve the final product samples in the first few days of January and expect to commence shipping products by the third week of January. The first products to be shipped will be the Breathing Formula, Sinus Formula, Kidney Formula and the Prostate Formula. A few weeks thereafter the Cold & Flu Formula and Weight Loss Formula should go into production. 
 
Robert deZanger, CEO of Natures Bioceuticals stated “We continue to receive numerous emails and phones calls daily from people, both domestic and international, interested in trying our unique natural products. The current staff is overwhelmed trying to respond to people seeking information and products. We have also received vast interest from people seeking to distribute our products in various parts of the world. News stations, radio stations and many periodicals continue to request interviews and are desirous of publishing articles about our company and products or including us in industry related informational articles.  We are excited about the response we have been getting as it confirms our belief that there is a great demand for our products”.
 
About Nature’s Bioceuticals: Nature’s Bioceuticals develops and acquires the rights to natural medicine formulas that are geared towards treating specific medical conditions. These medicines are all natural and derived from botanicals and mineral bases. Nature’s Bioceuticals strives to provide high quality natural medicines that are as effective, if not more effective, than synthetic drugs and more importantly do not have the negative side effects usually associated with many of today’s prescribed drugs.
 
Nature’s line of natural medicines will be either sold as prescription drugs, if applied for by the company and approved by the FDA, or sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994, commonly referred to as "DSHEA"
 
In addition to historical information, this release contains forward-looking statements. Mistral Ventures, Inc. and/or Nature’s Bioceuticals may, from time to time, make written or oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements encompass Mistral Ventures, Inc. and/or Nature’s Bioceuticals beliefs, expectations, hopes, or intentions regarding future events. Words such as “expects,” “intends,” “believes,” “anticipates,” “should,” “likely,” and similar expressions identify forward-looking statements. All forward-looking statements included in this release are made as of the date hereof and are based on information available to the Company as of such date. Neither Mistral Ventures, Inc. nor Nature’s Bioceuticals assume any obligation to update any forward-looking statement. Actual results will vary, and may vary materially, from those anticipated, estimated, projected or expected for a number of reasons, including, among others: further reviews of the Company’s financial statements by the Company and its Audit Committee; modification of the Company’s accounting practices; foreign business risks; industry cyclicality; fluctuations in customer demand and order pattern; changes in pricing and general economic conditions; as well as other risks that may be delineated from time to time or filed with the SEC.
 
Media Contact: Financial Insights
Phone Number: 888 656 3509
E-mail: investors@naturesbioceuticals.com
www.naturesbioceuticals.com